Government and Regulations

Cholesterol Medications—Who Isn’t Taking Them?

Research from the CDC finds half of Americans who should be taking cholesterol medications are not.


 

According to Morbidity and Mortality Weekly Report, nearly half of American adults who could be taking cholesterol-lowering medicines are not. CDC researchers examined data from the 2005-2012 National Health and Nutrition Examination Surveys and found that 78 million people aged 21 or older (37% of American adults) were eligible for cholesterol-lowering medication or already taking it. Of those, 56% were taking medication, 47% were making lifestyle changes, 37% were doing both, and 36% were doing neither.

Black adults who did not have a routine place for health care were found least likely to be taking cholesterol-lowering drugs. However, the CDC study also found that black men have a lower prevalence of high cholesterol compared with whites and Hispanics.

Although the study included all forms of cholesterol-lowering medications, nearly 90% of patients were taking statins.

Recommended Reading

Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population
Federal Practitioner
Treatment Failure With Atorvastatin After Change From Rosuvastatin to Atorvastatin
Federal Practitioner
Eating Better for Improved Cognition
Federal Practitioner
Does Heart Failure Make “Reading People” Harder?
Federal Practitioner
Preventing CVD with Clinical Decision Support Systems
Federal Practitioner
Hyponatremia Secondary to Lisinopril in a Veteran Patient
Federal Practitioner
Impact of Patient Aligned Care Team Interprofessional Care Updates on Metabolic Parameters
Federal Practitioner
VA Facilities Compare Favorably in Large-Scale Comparative Study
Federal Practitioner
Long-Term Smoking Raises Cardiopulmonary Risks in Patients With HIV
Federal Practitioner
Swallowing Problems After Cardiac Surgery With Intubation
Federal Practitioner

Related Articles